the products (medicines, supplies and tools) to us. This affect to sales and services are not in line the target. And Medical Vision Co., Ltd. has a cost of goods sold from pneumatic tube carrier

spike in cases of new variant in 2Q21 and still continue, as well as the issue on vaccine supplies. Our network capex remains between 25-30bn to ensure we invest for leadership both on network quality and

% Accrued R/S expense 3,361 1.0 % 3,361 1.0 % CP of spectrum payable 10,903 3.2 % 10,928 3.3 % Others 26,231 7.8 % 39,536 12 % Current Liabilities 96,341 29 % 99,326 30 % Debenture & LT loans 63,914 19

payable 24,215 7.2% 16,503 5.1% ST loan & CP of LT loans 20,496 6.1% 14,549 4.5% CP of lease liabilities 11,135 3.3% 11,225 3.4% Accrued R/S expense 3,361 1.0% 3,361 1.0% CP of spectrum payable 10,903 3.2

% 27,060 8.4 % CP of lease liabilities 11,135 3.3 % 11,285 3.5 % Accrued R/S expense 3,361 1.0 % 3,361 1.0 % CP of spectrum payable 10,903 3.2 % 10,827 3.4 % Others 26,231 7.8 % 22,959 7.1 % Current

duration, resulting in a shortened estimated useful lives. (6) Repair and maintenance expenses, increased by THB 11.10 million from renovation of existing branches. (7) Other expenses included supplies

driven by glycerine supply glut from increasing biodiesel blending rate of leading biodiesel producers in global market significantly affected to the company’ s methyl ester business. However, fatty

10,608 / ton or 61.93%, comparing to the 1st quarter of 2014. Due to decreased in Biodiesel production as mentioned above and the Company used most of its by-products as raw materials in B100 production to

2014. Due to decreased in Biodiesel production as mentioned above and the Company used most of its by-products as raw materials in B100 production to reduce Biodiesel’s production cost, which made

raw materials used in production was lower than the year 2018. 6. Cost of installation of pipes for the year 2019 was 89.75% of income. The cost per income rate decreased from the year 2018 which was